Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18026 - 18050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	COQ10B	80219	upregulated	[NSC 689534 binds to Copper] which results in increased expression of COQ10B mRNA	2q33.1	A21749
Copper	Approved Investigational	COQ8A	56997	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of COQ8A mRNA	1q42.13	A21749
Copper	Approved Investigational	COX11	1353	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of COX11 mRNA	17q22	A21749
Copper	Approved Investigational	COX19	90639	upregulated	[NSC 689534 binds to Copper] which results in increased expression of COX19 mRNA	7p22.3	A21749
Copper	Approved Investigational	COX5A	9377	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of COX5A mRNA	15q24.2	A21749
Copper	Approved Investigational	COX7B	1349	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of COX7B mRNA	Xq21.1	A21749
Copper	Approved Investigational	CPA4	51200	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CPA4 mRNA	7q32.2	A21749
Copper	Approved Investigational	CPEB2	132864	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CPEB2 mRNA	4p15.32	A21749
Copper	Approved Investigational	CPEB3	22849	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CPEB3 mRNA	10q23.32	A21749
Copper	Approved Investigational	CPEB4	80315	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CPEB4 mRNA	5q35.2	A21749
Copper	Approved Investigational	CPNE8	144402	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CPNE8 mRNA	12q12	A21749
Copper	Approved Investigational	CPSF3	51692	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CPSF3 mRNA	2p25.1	A21749
Copper	Approved Investigational	CPSF6	11052	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CPSF6 mRNA	12q15	A21749
Copper	Approved Investigational	CRABP2	1382	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CRABP2 mRNA	1q23.1	A21750
Copper	Approved Investigational	CRABP2	1382	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CRABP2 mRNA	1q23.1	A21749
Copper	Approved Investigational	CREBRF	153222	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CREBRF mRNA	5q35.1	A21749
Copper	Approved Investigational	CREG2	200407	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of CREG2 mRNA	2q11.2	A21749
Copper	Approved Investigational	CRELD2	79174	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CRELD2 mRNA	22q13.33	A21750
Copper	Approved Investigational	CREM	1390	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CREM mRNA	10p11.21	A21749
Copper	Approved Investigational	CRIM1	51232	upregulated	[Disulfiram binds to Copper] which results in increased expression of CRIM1 mRNA	2p22.2	A21750
Copper	Approved Investigational	CRIPT	9419	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CRIPT mRNA	2p21	A21750
Copper	Approved Investigational	CRISPLD2	83716	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CRISPLD2 mRNA	16q24.1	A21750
Copper	Approved Investigational	CRISPLD2	83716	upregulated	[NSC 689534 binds to Copper] which results in increased expression of CRISPLD2 mRNA	16q24.1	A21749
Copper	Approved Investigational	CRYAB	1410	upregulated	Copper results in increased expression of CRYAB mRNA	11q23.1	A21752
Copper	Approved Investigational	CRYAB	1410	downregulated	[Disulfiram binds to Copper] which results in decreased expression of CRYAB mRNA	11q23.1	A21750

Displaying entries 18026 - 18050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability